New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy.
about
Exploiting Genetic Interference for Antiviral TherapyRetroviral integrations in gene therapy trialsAdipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseasesOligo/polynucleotide-based gene modification: strategies and therapeutic potentialTowards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.Serial bone marrow transplantation reveals in vivo expression of the pCLPG retroviral vector.Autonomous targeting of infectious superspreaders using engineered transmissible therapies.Octa-arginine mediated delivery of wild-type Lnk protein inhibits TPO-induced M-MOK megakaryoblastic leukemic cell growth by promoting apoptosis.Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.Promoted Growth of Brain Tumor by the Transplantation of Neural Stem/Progenitor Cells Facilitated by CXCL12.Retroviral integration site selection.Characterization of Equine Infectious Anemia Virus Integration in the Horse GenomeIntegrase, LEDGF/p75 and HIV replication.Stem and progenitor cell-mediated tumor selective gene therapy.Recent advances in gene therapy for severe congenital immunodeficiency diseasesTowards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?Applications of neural and mesenchymal stem cells in the treatment of gliomas.The therapeutic potential of stem cells.The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research.Gene therapy in thalassemia and hemoglobinopathies.Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications.Viral vectors for gene delivery to the central nervous system.Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions.Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?Recent gene therapy advancements for neurological diseases.Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.LMO2 at 25 years: a paradigm of chromosomal translocation proteins.The functional relationship between hematopoietic stem cells and developing T lymphocytes.Hotspots of MLV integration in the hematopoietic tumor genomeTherapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.Identification of a high incidence region for retroviral vector integration near exon 1 of the LMO2 locus.The development of T cells from stem cells in mice and humans.Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotide.Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man.Development of Multifunctional Magnetic Nanoparticles for Genetic Engineering and Tracking of Neural Stem Cells.Lmo2 expression defines tumor cell identity during T-cell leukemogenesisHerpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System
P2860
Q24288775-48F91477-9519-45A9-8E11-3DB01DD2F628Q26991660-ACB7701A-493B-4A1C-91C4-799C2DC90181Q27011815-D6D94688-0055-4514-B3F4-248F4BD9849AQ28307657-7BEE6961-240A-46BD-B1BB-A2015FA440A9Q33489590-132DAAAF-E7D4-4E0D-9D2C-49F0DCD104E4Q33753483-67EA17D4-5DEC-483B-9DEB-503CCE8C7127Q33868991-77A95AA4-E60A-466A-85FB-5535D7B51964Q33997280-64A8E0D2-993B-44E2-8BD1-978D25F611CFQ34084756-72380F4C-111C-4A1A-8662-7CC34F227AF9Q34092169-DD735F12-BB44-46D6-886E-F7712907D8CDQ35260206-9A6DFDE0-7604-480C-AC1F-42C631869F04Q35808693-960364A4-ED8A-476B-90C0-EA49230638EAQ37081043-22B99C54-1824-4BF1-A464-58B9BB1AEB0EQ37120161-D666F65F-FD03-49CE-B056-352FFDF3A86CQ37153580-E5935B92-7B07-409B-8150-672E7D709464Q37205966-A4D5E3CD-7ED9-4F53-B4FB-EADF206C073AQ37260299-9ADC14F8-A72C-4DC3-B0EC-116C5421BAD9Q37483966-03F4FDC5-2FB8-4975-97A9-4B5DDE332349Q37653368-F3FD0211-FEE9-4367-9C8F-42AC63E284CFQ37758303-1E4D6A24-DEB4-428C-B5BB-9E9CC7F362AAQ37854468-3498A8CF-C58F-420F-8B4F-C1489F0AA13EQ37870053-62F9185A-39E2-4FD4-9C1E-7AEE8D2BF480Q37946113-930A8C42-7FFC-48B7-83F1-70F2C9AE1011Q37952805-D1F4F5CE-A7C6-4633-8997-14C389FE20D6Q37995010-E1804F97-2E7E-40C5-A9C7-E1D09BF87229Q38062875-3871874F-0DD3-4F1A-8CBC-C0C3A73487ACQ38085469-60464B97-F9DE-42CF-83DC-A5EEB2101910Q38245751-A67E2F08-122C-4360-9A75-F422217E2CA7Q38537084-71D680CB-286C-4C8D-8441-C7C55C86D730Q38698470-816DA539-3467-4DF0-BB5A-2FFE50A2F7CEQ38976712-C820F17A-1AE8-4474-96E8-C0E1BCCFF262Q39323223-B0E57924-16F8-40B9-B70D-4A1932D4D2D0Q39804575-688600B8-5B41-48B6-839D-3C75F9815387Q41609272-F1C41CB6-E37B-4D01-A444-C82704A29111Q41948139-BDBC85E0-5959-4468-BF5F-76760C84C47EQ43685735-9F0CD90E-1599-4EE5-822F-72047AC9791CQ45870581-965A00C0-172D-44D9-B56D-6B86CE44FACDQ48628755-17D3B5F2-96BF-4DF4-AFD7-8B85823AC689Q58051449-28B4F8D1-9DFE-4570-B1A1-8E7D03012D2AQ58779571-54FBF00D-99D4-4E9F-9089-38063C3ACB3D
P2860
New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
New insights and unresolved is ...... in X-linked SCID gene therapy.
@en
type
label
New insights and unresolved is ...... in X-linked SCID gene therapy.
@en
prefLabel
New insights and unresolved is ...... in X-linked SCID gene therapy.
@en
P2093
P356
P1433
P1476
New insights and unresolved is ...... in X-linked SCID gene therapy.
@en
P2093
Frank J T Staal
Gerard Wagemaker
Jacques J M van Dongen
Karin Pike-Overzet
Mirjam van der Burg
P304
P356
10.1038/SJ.MT.6300297
P577
2007-08-28T00:00:00Z